logo

For the Inventor, By the Inventor

Seoul, South Korea

Kwangmeyung Kim

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:

goldMedal11 out of 2,169 
 
Korea Institute of Science and Technology
 patents
silverMedal1 out of 1,147 
 
Korea University Research and Business Foundation
 patents
where one patent can have more than one assignee

Years Active: 2013-2023

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 11833204 - Visible light-activatable nanoparticles for cancer immunotherapy and use thereof (2023-12-05),
2. 11498946 - Pharmaceutical composition for combination therapy for preventing or treating cancer containing tumor-specific drug conjugate and anti-PD-L1 antibody as active ingredients (2022-11-15),
3. 11246939 - Immunoregulatory protein-siRNA complex having anticancer activity (2022-02-15),
4. 11015197 - Therapeutic agent for treating cancer comprising anti-miRNA-albumin composite (2021-05-25),
5. 10905774 - Nanocage and use thereof (2021-02-02),
6. 10610602 - Tumor cell-specific responsive self-assembling drug nanoconjugate (2020-04-07),
7. 10213515 - Glycopeptide for contrast agent targeting cancer cells and contrast agent kit containing the same (2019-02-26),
8. 10206987 - Protein nanoparticle linked with cancer specific epitope and composition for cancer immunotherapy comprising the same (2019-02-19),
9. 8530047 - Method for polymerizing a small oligonucleotide, and use of a high-molecular oligonucleotide prepared by the polymerization method (2013-09-10),
10. 8513402 - Human serum albumin-siRNA nano-sized carrier system (2013-08-20),
11. 8367042 - Nanoparticles of light emissive polymers and preparation method thereof (2013-02-05),

Title: Innovations of Kwangmeyung Kim in Cancer Therapy

Introduction

Kwangmeyung Kim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer therapy, holding a total of 11 patents. His work focuses on developing innovative solutions that enhance the efficacy of cancer treatments.

Latest Patents

Among his latest patents is the invention of visible light-activatable nanoparticles for cancer immunotherapy. These nanoparticles are designed to induce potent apoptosis in cancer cells while increasing their own anticancer immunogenicity. This innovation maximizes therapeutic efficacy against cancer. Another notable patent is a pharmaceutical composition for combination therapy aimed at preventing or treating cancer. This composition includes a tumor-specific drug conjugate and an anti-PD-L1 antibody as active ingredients. It has shown significant inhibition of cancer growth in in-vivo experiments and enhances the immunotherapeutic effect by activating immune cells in cancerous tissues. The composition demonstrates superior tumor accumulation efficiency and selectivity compared to existing anticancer agents, with minimal toxicity to normal tissues.

Career Highlights

Kwangmeyung Kim has worked with esteemed institutions such as the Korea Institute of Science and Technology and the Korea University Research and Business Foundation. His research and innovations have positioned him as a key figure in the development of advanced cancer therapies.

Collaborations

He has collaborated with notable colleagues, including Ick Chan Kwon and Ju Hee Ryu, contributing to the advancement of cancer treatment technologies.

Conclusion

Kwangmeyung Kim's innovative work in cancer therapy showcases his dedication to improving treatment outcomes for patients. His patents reflect a commitment to harnessing technology for better health solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…